Thioether derivatives as protein kinase inhibitors
EP2733146A1
Thioether derivatives as protein kinase inhibitors
US2013012473A1
Combined use of phospholipid and sulfate groups-carrying polysaccharides for inhibiting metastatic spread
EP2382993A1
Combination of drugs with protein-binding prodrugs
CN102413842A
Prodrugs
EP2289558A1
Bisphosphonate-prodrugs
EP2266964A1
Acid-labile trigger units
EP2123305A1
Linear self-eliminating oligomers
CA2687291A1
Low-viscous anthracycline formulation
EP2609934A1
Receptor And Antigen Targeted Prodrug
EP2085089A1
Phospholipids Containing omega-3-Fatty Acids for the Treatment of Overweight, Obesity and Addictive Behavior
EP2047849A1
Use of indolocarbazole imides as protein kinase inhibitors for the treatment of hematologic and solid tumors
AU2007263018A1
Alkylphospholipids as active agents for prevention of plant pathogens
EP1952803A1
Solid pharmaceutical dosage form containing hydrogenated phospholipids
EP1745788A1
Acyglycerophospholipids for treating cancer and cachexia
DE102005009084A1
New anthracyclin-peptide derivatives, useful for treating cancer, especially of the prostate, are cleaved, in the tumor, by prostate-specific antigen to release active antitumor agent and are transported by serum albumen
DE102005009099A1
New camptothecin-peptide derivatives, useful for treating cancer
EP1674081A1
Preparation of lipid based nano-particles with a dual asymetric centrifuge
DE10314780A1
Protein-binding derivatives of platinum complexes with cyclobutane-1,1-dicarboxylate ligands
